Guillaume Pfefer heads up Kala Pharma
This article was originally published in Scrip
Executive Summary
Kala Pharmaceuticals, a developer of products that penetrate the mucosal barrier to treat a wide range of diseases, has appointed Dr Guillaume Pfefer president and CEO and a member of the board of directors. Prior to joining Kala, Dr Pfefer served nine years at Sanofi Pasteur, most recently as general manager of Sanofi Pasteur Mexico.